SIRT1 and breast carcinoma: Yao et al. [45] and Santolla et al. [46] documented that SIRT1 is also involved in oncogenic signaling mediated by GPER (G-protein ER, formerly known as GPR30) in breast cancer by activating the EGFR/ERK/c-fos/AP-1 transduction pathway.